Topas Therapeutics GmbH
1 clinical trials · Sponsor
◉ Watch Topas Therapeutics GmbH
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety of TPM502 in Adults With Celiac Disease (NCT05660109) | Topas Therapeutics GmbH | 2022-12-12 |
Track Topas Therapeutics GmbH automatically
Every clearance here is in the API, with alerts when new ones post.